| RS2151299623 |
SRCAP
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2151299633 |
SRCAP
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2151300039 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS2151300055 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2151300137 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS2151300144 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2151300418 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Developmental delay |
| RS2151301004 |
SRCAP
|
Health Risk |
Likely pathogenic |
— |
| RS2151301216 |
SRCAP
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2151301366 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Developmental delay |
| RS2151303613 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151304304 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151304648 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2151305375 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151305935 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2151306395 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151306514 |
CREBBP
|
Health Risk |
Pathogenic |
Menke-Hennekam syndrome 1, Menke-Hennekam syndrome 1 |
| RS2151306905 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 |
| RS2151307419 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151308298 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151308835 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151309006 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151309318 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome |
| RS2151309510 |
CREBBP
|
Health Risk |
Likely pathogenic |
Menke-Hennekam syndrome 1, Menke-Hennekam syndrome 1 |
| RS2151309803 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151310104 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS2151310413 |
PHKG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS2151311363 |
CREBBP
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2151311520 |
CREBBP
|
Health Risk |
Likely pathogenic |
Tip-toe gait, Tip-toe gait |
| RS2151311712 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2151311733 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS2151311901 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151312423 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rare genetic intellectual disability, Rare genetic intellectual disability |
| RS2151315345 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151316174 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151316542 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151317319 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151317483 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2151317705 |
TSC2
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2151317974 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2151318037 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151318201 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2151318273 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151318564 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2151318827 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151319848 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS2151319998 |
LCAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Fish-eye disease, Norum disease |
| RS2151325186 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151325681 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2151325787 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151325875 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS2151327153 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151327314 |
ADAD2
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS2151327516 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151327706 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151327825 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2151327865 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS2151327974 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151327978 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151328709 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151329629 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151329858 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS2151330140 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151330226 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151334254 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151336580 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS2151336596 |
CREBBP
|
Health Risk |
Pathogenic |
Malignant lymphoma, large B-cell |
| RS2151341377 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151341681 |
DPH1
|
Health Risk |
Pathogenic |
Developmental delay with short stature, dysmorphic facial features |
| RS2151346636 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151346853 |
DPH1
|
Health Risk |
Likely pathogenic |
Developmental delay with short stature, dysmorphic facial features |
| RS2151347730 |
DPH1
|
Health Risk |
Likely pathogenic |
Developmental delay with short stature, dysmorphic facial features |
| RS2151347763 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151349354 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151351169 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151351558 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151352275 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151352359 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151352672 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2151353536 |
UNC45A
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteootohepatoenteric syndrome, Osteootohepatoenteric syndrome |
| RS2151353922 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151354104 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151356150 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS2151356741 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Isolated focal cortical dysplasia type II |
| RS2151356819 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151375529 |
KDM6B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151376850 |
KDM6B
|
Health Risk |
Pathogenic |
See cases, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151378140 |
KDM6B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151378447 |
KDM6B
|
Health Risk |
Likely pathogenic |
— |
| RS2151379290 |
KDM6B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151379380 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2151379742 |
KDM6B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151379880 |
KDM6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151380036 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151380462 |
KDM6B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2151380836 |
TSC2
|
Health Risk |
Pathogenic |
TSC2-related disorder, TSC2-related disorder |
| RS2151381815 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS2151382514 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151383341 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS2151383792 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |